| These highlights do not include all the information needed to use Methylphenidate Hydrochloride Extended-Release Capsules safely and effectively. See full prescribing information for Methylphenidate Hydrochloride Extended-Release Capsules Methylphenidate Hydrochloride Extended-Release Capsules, for oral use, CII Initial U.S. Approval: 1955 | Rhodes Pharmaceuticals LLC | Patheon Manufacturing Services LLC | Knoa Pharmaceuticals LLC | 20260529 | 8 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Lannett Company, Inc. | 20260528 | 13 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE extended-release capsules, for oral use, CII Initial U.S. Approval: 1955 | Amneal Pharmaceuticals of New York LLC | Amneal Pharmaceuticals of New York, LLC | 20260527 | 11 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE ORAL SOLUTION safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE ORAL SOLUTION METHYLPHENIDATE HYDROCHLORIDE ORAL SOLUTION, CII Initial U.S. Approval: 1955 | KVK-Tech, Inc. | ABHAI, LLC. | 20260511 | 10 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS. METHYLPHENIDATE hydrochloride extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Lannett Company, Inc. | 20260501 | 32 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS . METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Actavis Pharma, Inc. | 20260430 | 32 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Sun Pharmaceutical Industries, Inc. | Ohm Laboratories Inc. | 20260429 | 6 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Sun Pharmaceutical Industries, Inc. | Ohm Laboratories Inc. | 20260424 | 2 |
| These highlights do not include all the information needed to use methylphenidate hydrochloride extended-release tablets USP safely and effectively. See full prescribing information for METHYLPHENIDATE hydrochloride extended-release tablets USP. METHYLPHENIDATE hydrochloride extended-release tablets USP, for oral use, CII Initial U.S. Approval: 2000 | Trigen Laboratories, LLC | 20260424 | 54 |
| METHYLPHENIDATE hydrochloride extended-release tablets USP. These highlights do not include all the information needed to use methylphenidate hydrochloride extended-release tablets USP safely and effectively. See full prescribing information for METHYLPHENIDATE hydrochloride extended-release tablets USP. METHYLPHENIDATE hydrochloride extended-release tablets USP, for oral use, CII Initial U.S. Approval: 2000 | Golden State Medical Supply, Inc. | Osmotica Pharmaceutical US LLC | 20260423 | 3 |
| Methylphenidate hydrochloride extended-release tablets, USP These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 1955 | Golden State Medical Supply, Inc. | Granules Pharmaceuticals Inc. | 20260423 | 7 |
| These highlights do not include all the information needed to use CONCERTA safely and effectively. See full prescribing information for CONCERTA. CONCERTA ® (methylphenidate hydrochloride) extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Janssen Pharmaceuticals, Inc. | AndersonBrecon Inc. | Janssen Ortho LLC | Janssen-Cilag Manufacturing, LLC | 20260420 | 30 |
| These highlights do not include all the information needed to use QUILLICHEW ER ® safely and effectively. See full prescribing information for QUILLICHEW ER ® . QUILLICHEW ER ® (methylphenidate hydrochloride) extended-release chewable tablets , for oral use, CII Initial U.S. Approval: 1955 | NextWave Pharmaceuticals, Inc | 20260408 | 30 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Northstar Rx LLC | Ohm Laboratories Inc. | 20260402 | 2 |
| These highlights do not include all the information needed to use QUILLIVANT XR ® safely and effectively. See full prescribing information for QUILLIVANT XR ® . QUILLIVANT XR ® (methylphenidate hydrochloride) for extended-release oral suspension, CII Initial U.S. Approval: 1955 | NextWave Pharmaceuticals, Inc | 20260320 | 20 |
| Methylphenidate hydrochloride extended-release tablets, USP These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 1955 | Granules Pharmaceuticals Inc. | 20260317 | 10 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS. METHYLPHENIDATE hydrochloride extended-release tablets, USP for oral use CII Initial U.S. Approval: 2000 | Bryant Ranch Prepack | 20260317 | 102 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS. METHYLPHENIDATE hydrochloride extended-release tablets, USP for oral use CII Initial U.S. Approval: 2000 | Bryant Ranch Prepack | 20260317 | 102 |
| Methylphenidate Hydrochloride Extended-Release Tablets, USP CII Rx Only These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. Initial U.S. Approval: 2000 | AvPAK | 20260108 | 4 |
| Methylphenidate Hydrochloride Tablets, USP These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. Initial U.S. Approval: 1955 | AvPAK | 20260108 | 5 |
| These highlights do not include all the information needed to use Methylphenidate Hydrochloride Tablets USP CII safely and effectively. See full prescribing information for Methylphenidate Hydrochloride Tablets USP CII. Methylphenidate hydrochloride tablets, for oral use, CII Initial U.S. Approval: 1955 | KVK-TECH, INC. | Abhai, LLC | 20260102 | 14 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | American Health Packaging | 20251204 | 6 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HCl EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HCl EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HCl extended-release capsules, CII Initial U.S. Approval: 1955 | SpecGx LLC | 20251201 | 28 |
| These highlights do not include all the information needed to use METADATE CD ® safely and effectively. See full prescribing information for METADATE CD. METADATE CD (methylphenidate hydrochloride) extended-release capsules, CII Initial U.S. Approval: 1955 | Aytu BioPharma, Inc. | 20251118 | 6 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Bryant Ranch Prepack | 20251111 | 100 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA) safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA). METHYLPHENIDATE HYDROCHLORIDE extended-release capsules (LA) for oral use, CII Initial U.S. Approval: 1955 | Mayne Pharma | Sharp Corporation | 20251106 | 10 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE extended-release capsules, for oral use, CII Initial U.S. Approval: 1955 | Actavis Pharma, Inc. | 20251031 | 16 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | American Health Packaging | 20251022 | 11 |
| METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE extended-release capsules, for oral use, CII Initial U.S. Approval: 1955 | Granules Pharmaceuticals Inc. | 20251008 | 12 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 1955 | SpecGx LLC | 20251008 | 3 |
| These highlights do not include all the information needed to use Methylphenidate Hydrochloride Extended-Release Tablets USP CII safely and effectively. See full prescribing information for Methylphenidate Hydrochloride Extended-Release Tablets USP CII. Methylphenidate hydrochloride extended-release tablets, for oral use, CII Initial U.S. Approval: 1955 | KVK-Tech, Inc. | ABHAI LLC | 20251007 | 14 |
| These highlights do not include all the information needed to use METHYLPHENIDATE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for METHYLPHENIDATE TRANSDERMAL SYSTEM. METHYLPHENIDATE transdermal system Initial U.S. Approval: 2006 | Mylan Pharmaceuticals Inc. | 20251007 | 6 |
| These highlights do not include all the information needed to use JORNAY PM® safely and effectively. See full prescribing information for JORNAY PM. JORNAY PM (methylphenidate hydrochloride) extended-release capsules, for oral use, CII Initial U.S. Approval: 1955 | Ironshore Pharmaceuticals Inc. | Patheon Puerto Rico, Inc. | 20251003 | 16 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA) safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA). METHYLPHENIDATE HYDROCHLORIDE extended-release capsules (LA) for oral use, CII Initial U.S. Approval: 1955 | Dr. Reddy's Laboratories Inc | 20250930 | 2 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE. METHYLPHENIDATE HYDROCHLORIDE extended-release capsules CD, CII Initial U.S. Approval: 1955 | Lannett Company, Inc. | 20250930 | 8 |
| These highlights do not include all the information needed to use methylphenidate hydrochloride extended-release tablets safely and effectively. See full prescribing information for methylphenidate hydrochloride extended-release tablets. Methylphenidate hydrochloride extended-release tablets for oral use, CII Initial U.S. Approval: 2000 | Trigen Laboratories, LLC | 20250926 | 48 |
| These highlights do not include all the information needed to use RELEXXII ® safely and effectively. See full prescribing information for RELEXXII ® . RELEXXII ® (methylphenidate hydrochloride extended-release tablets) for oral use, CII Initial U.S. Approval: 2000 | Vertical Pharmaceuticals, LLC | 20250926 | 18 |
| These highlights do not include all the information needed to use METHYLPHENIDATE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for METHYLPHENIDATE TRANSDERMAL SYSTEM. Methylphenidate Transdermal System, CII Initial U.S. Approval: 2006 | PADAGIS US LLC | NOVEN PHARMACEUTICALS, INC. | 20250925 | 7 |
| These highlights do not include all the information needed to use COTEMPLA XR-ODT safely and effectively. See full prescribing information for COTEMPLA XR-ODT. COTEMPLA XR-ODT (methylphenidate extended-release orally disintegrating tablets), CII Initial U.S. Approval: 1955 | Neos Therapeutics Brands, LLC | Aphena Pharma Solutions | Halo Pharmaceuticals, Inc. | 20250924 | 15 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE Extended-Release Capsules for oral use, CII Initial U.S. Approval: 1955 | Sandoz Inc | 20250923 | 8 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE Extended-Release Capsules for oral use, CII Initial U.S. Approval: 1955 | Sandoz Inc | 20250923 | 4 |
| These highlights do not include all the information needed to use RITALIN LA safely and effectively. See full prescribing information for RITALIN LA. RITALIN LA ® (methylphenidate hydrochloride) extended-release capsules for oral use, CII Initial U.S. Approval: 1955 | Novartis Pharmaceuticals Corporation | 20250923 | 36 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. Methylphenidate hydrochloride tablets, for oral use, CII Initial U.S. Approval: 1955 | Solco Healthcare US,LLC | Prinston Pharmaceutical Inc. | Generics Bidco ⅡLLC | 20250918 | 7 |
| These highlights do not include all the information needed to use DAYTRANA ® safely and effectively. See full prescribing information for DAYTRANA. DAYTRANA ® (methylphenidate transdermal system), CII Initial U.S. Approval: 2006 | Noven Therapeutics, LLC | Noven Pharmaceuticals, Inc. | 20250901 | 29 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Camber Pharmaceutical Inc | Ascent pharmaceutical Inc | 20250806 | 9 |
| Methlyphenidate Hydrochloride Tablets, USP CII These highlights do not include all the information needed to use Methlyphenidate Hydrochloride Tablet safely and effectively. See full prescribing information for Methlyphenidate Hydrochloride Tablet. Initial U.S. Approval: 1955 | Aurolife Pharma, LLC | JANSSEN PHARMACEUTICALS, INC. | 20250603 | 4 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Bryant Ranch Prepack | 20250401 | 102 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Bryant Ranch Prepack | 20250317 | 6 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE Chewable Tablets s afely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE Chewable Tablets . METHYLPHENIDATE HYDROCHLORIDE Chewable Tablets (Methylphenidate hydrochloride), for oral use, CII Initial U.S. Approval: 1955 | Rising Pharma Holdings, Inc. | Tedor Pharma Inc. | 20250312 | 7 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Sun Pharmaceutical Industries, Inc. | Ohm Laboratories Inc. | 20250227 | 16 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Amneal Pharmaceuticals of New York LLC | Amneal Pharmaceuticals of New York, LLC | Johnson Matthey Inc. | 20250219 | 12 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Neolpharma, Inc. | 20250212 | 18 |
| These highlights do not include all the information needed to use RITALIN safely and effectively. See full prescribing information for RITALIN. RITALIN ® (methylphenidate hydrochloride) tablets, for oral use, CII Initial U.S. Approval: 1955 | Novartis Pharmaceuticals Corporation | 20250205 | 32 |
| These highlights do not include all the information needed to use RITALIN safely and effectively. See full prescribing information for RITALIN. RITALIN ® (methylphenidate hydrochloride) tablets, for oral use, CII Initial U.S. Approval: 1955 | Sandoz Inc | 20250205 | 3 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE ORAL SOLUTION safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE ORAL SOLUTION . METHYLPHENIDATE HYDROCHLORIDE Oral Solution, CII Initial U.S. Approval: 1955 | Cranbury Pharmaceuticals, LLC | 20250130 | 22 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Bryant Ranch Prepack | 20241118 | 100 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Bryant Ranch Prepack | 20241118 | 100 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Bryant Ranch Prepack | 20241118 | 100 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Bryant Ranch Prepack | 20241031 | 4 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | SpecGx LLC | 20240901 | 34 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Ascend Laboratories, LLC | Alkem Laboratories Limited | 20240715 | 9 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Accord Healthcare, Inc. | WES Pharma Inc. | 20240618 | 7 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE ORAL SOLUTION safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE ORAL SOLUTION . METHYLPHENIDATE HYDROCHLORIDE Oral Solution, CII Initial U.S. Approval: 1955 | Bryant Ranch Prepack | 20240403 | 102 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE ORAL SOLUTION safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE ORAL SOLUTION . METHYLPHENIDATE HYDROCHLORIDE Oral Solution, CII Initial U.S. Approval: 1955 | Bryant Ranch Prepack | 20240403 | 102 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE oral solution safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE oral solution. METHYLPHENIDATE HYDROCHLORIDE oral solution, CII Initial U.S. Approval: 1955 | Bryant Ranch Prepack | 20240403 | 101 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Bryant Ranch Prepack | 20240403 | 101 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Bryant Ranch Prepack | 20240403 | 102 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Bryant Ranch Prepack | 20240403 | 101 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE oral solution safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE oral solution. METHYLPHENIDATE HYDROCHLORIDE oral solution, CII Initial U.S. Approval: 1955 | Bryant Ranch Prepack | 20240402 | 102 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Lupin Pharmaceuticals,Inc. | Novel Laboratories, Inc. | 20240321 | 8 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Nivagen Pharmaceuticals, Inc. | 20240226 | 1 |
| Methylphenidate HCl Chewable Tablet, CII Rx only | Bryant Ranch Prepack | 20240205 | 100 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE oral solution safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE oral solution. METHYLPHENIDATE HYDROCHLORIDE oral solution, CII Initial U.S. Approval: 1955 | Bryant Ranch Prepack | 20240205 | 100 |
| Methylphenidate Hydrochloride Oral Solution, 5 mg/5 mL Methylphenidate Hydrochloride Oral Solution, 10 mg/5 mL CII Rx only | Bryant Ranch Prepack | 20240110 | 6 |
| Methylphenidate Hydrochloride Chewable Tablets CII 2.5 mg, 5 mg and 10 mg Rx only | Bryant Ranch Prepack | 20240109 | 103 |
| Methylphenidate Hydrochloride Chewable Tablets CII 2.5 mg, 5 mg and 10 mg Rx only | Bryant Ranch Prepack | 20240109 | 103 |
| Methylphenidate Hydrochloride Chewable Tablets CII 2.5 mg, 5 mg and 10 mg Rx only | Bryant Ranch Prepack | 20240109 | 103 |
| Methylphenidate HCl Chewable Tablets CII Rx only | Lupin Pharmaceuticals,Inc. | Novel Laboratories, Inc. | 20231211 | 7 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE ORAL SOLUTION safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE ORAL SOLUTION. METHYLPHENIDATE HYDROCHLORIDE oral solution, CII Initial U.S. Approval: 1955 | Lupin Pharmaceuticals,Inc. | Novel Laboratories, Inc. | 20231211 | 6 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE oral solution safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE oral solution. METHYLPHENIDATE HYDROCHLORIDE oral solution, CII Initial U.S. Approval: 1955 | Eywa Pharma Inc | Wes Pharma Inc | 20231108 | 6 |
| These highlights do not include all the information needed to use METHYLIN ® s afely and effectively. See full prescribing information for METHYLIN ® . METHYLIN ® (methylphenidate hydrochloride) oral solution, CII Initial U.S. Approval: 1955 | SHIONOGI INC. | SpecGx LLC | 20231101 | 32 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | SpecGx LLC | 20231001 | 44 |
| Methylphenidate HCl Chewable Tablet, CII Rx only | XLCare Pharmaceuticals, Inc. | Ascent Pharmaceuticals Inc | 20230928 | 4 |
| Methylphenidate HCl Chewable Tablet, CII Rx only | Camber Pharmaceuticals Inc. | Ascent Pharmaceuticals Inc | 20230927 | 5 |
| Methylphenidate HCl Oral Solution, 5 mg/5 mL Methylphenidate HCl Oral Solution, 10 mg/5 mL CII Rx only | QUAGEN PHARMACEUTICALS LLC | 20230202 | 2 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 1955 | Ascend Laboratories, LLC | Alkem Laboratories | 20220920 | 7 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE ORAL SOLUTION safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE ORAL SOLUTION. METHYLPHENIDATE HYDROCHLORIDE oral solution, CII Initial U.S. Approval: 1955 | Ascend Laboratories, LLC | Alkem Laboratories Limited | 20211229 | 5 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORILDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORILDE EXTENDED-RELEASE TABLETS . METHYLPHENIDATE HYDROCHLORILDE extended-release tablets CII Initial U.S. Approval: 2000 | Dr.Reddys Laboratories Inc | Dr. Reddy's Laboratories LLC. | 20211203 | 7 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | XLCare Pharmaceuticals Inc | Ascent pharmaceutical Inc | 20210818 | 2 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | XLCare Pharmaceuticals, Inc. | Ascent Pharmaceuticals, Inc. | 20210817 | 2 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Camber Pharmaceuticals, Inc. | Ascent Pharmaceuticals, Inc. | 20210817 | 2 |
| Methylphenidate HCl oral solution, 5 mg/5 mL Methylphenidate HCl oral solution, 10 mg/5 mL CII Rx Only | Ascent Pharmaceuticals, Inc. | 20210129 | 3 |
| Methylphenidate HCl Oral Solution | Patrin Pharma, Inc. | 20200422 | 1 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES LA safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES LA . METHYLPHENIDATE HYDROCHLORIDE extended-release capsules for oral use, CII Initial U.S. Approval: 1955 | Teva Pharmaceuticals USA, Inc. | 20191231 | 10 |
| Methylphenidate HCl Chewable Tablets CII | Novel Laboratories, Inc. | 20191220 | 5 |
| Metadate ® ER Tablets (methylphenidate hydrochloride extended-release tablets, USP) CII | Upstate Pharma, LLC | 20170522 | 4 |
| METHYLPHENIDATE HYDROCHLORIDE TABLETS, USP CII | Upstate Pharma, LLC | 20170522 | 4 |
| Methylphenidate Hydrochloride Tablets, USP CII Rx only Prescribing Information | Novel Laboratories, Inc. | 20160105 | 4 |
| Methylphenidate Hydrochloride Oral Solution, 5 mg/5 mL CII Methylphenidate Hydrochloride Oral Solution, 10 mg/5 mL CII Rx Only | Novel laboratories, Inc. | 20150827 | 4 |
| Metadate ® ER Tablets (methylphenidate hydrochloride extended-release tablets, USP) CII | Unither Manufacturing, LLC | 20140106 | 9 |
| METHYLPHENIDATE HYDROCHLORIDE TABLETS, USP CII | Unither Manufacturing, LLC | 20140106 | 9 |
| Ritalin | Physicians Total Care, Inc. | 20120120 | 1 |
| These highlights do not include all the information needed to use Methylphenidate HCl Extended-Release Tablets safely and effectively. See full prescribing information for Methylphenidate HCl Extended-Release Tablets. Methylphenidate HCl Extended-Release Tablets CII Initial U.S. Approval: 2000 | Physicians Total Care, Inc. | 20110516 | 1 |
| Metadate CD ® (methylphenidate HCl, USP) Extended-Release Capsules CII | Physicians Total Care, Inc. | 20101101 | 1 |
| These highlights do not include all the information needed to use CONCERTA ® safely and effectively. See full prescribing information for CONCERTA ® . CONCERTA ® (methylphenidate HCl) Extended-Release Tablets CII Initial U.S. Approval: 2000 | Physicians Total Care, Inc. | 20101101 | 1 |
| f931d3af-c32a-4406-8799-9b097f41594b | Physicians Total Care, Inc. | 20100616 | 2 |
| methylphenidate hydrochloride 10mg Tablet | bryant ranch prepack | 20100201 | 1 |
| 330e620f-4b7f-4101-91dd-feddb7a823ed | Physicians Total Care, Inc. | 20091016 | 7 |
| d356f9f6-d094-478d-bf79-7781490588cc | STAT RX USA LLC | 20090522 | 1 |
| Methylphenidate Hydrochloride Tablets, USP Methylphenidate Hydrochloride Extended-Release Tablets, USP | UCB Pharma, Inc. | 20060919 | 3 |